Crinetics Pharmaceuticals (CRNX) EBIT Margin (2017 - 2026)
Crinetics Pharmaceuticals' quarterly EBIT Margin came in at 1307.79% in Q1 2026, up 2955232.0% year-on-year from N/an in Q1 2025, and up 39.72% quarter-over-quarter from 2169.55% in Q4 2025.
Crinetics Pharmaceuticals has reported EBIT Margin for 10 years, with the latest figure at 1307.79% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin rose 2955232.0% year-over-year to 1307.79%; the trailing twelve-month figure through Mar 2026 stood at 3020.32% (up 4654941.0% YoY), and the FY2025 full-year result was 6714.77%, up 2589870.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 1307.79%, up from 2169.55% in the prior quarter.
- The five-year high for EBIT Margin was 1080.39% in Q1 2022, with the low at 99710.49% in Q3 2025.
- Average EBIT Margin over 5 years is 16434.89%, with a median of 9646.51% recorded in 2022.
- Year-over-year, EBIT Margin sank 1937120 bps in 2025 and soared 2955232 bps in 2026.
- Tracing CRNX's EBIT Margin over 5 years: stood at 6707.48% in 2022, then tumbled by 154 bps to 17045.38% in 2023, then dropped by 22 bps to 20747.62% in 2024, then soared by 90 bps to 2169.55% in 2025, then soared by 40 bps to 1307.79% in 2026.
- The last three EBIT Margin figures came in at 1307.79% (Q1 2026), 2169.55% (Q4 2025), and 99710.49% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.02% |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | -1,307.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,307.79% |
| Dec 31, 2025 | -2,169.55% |
| Sep 30, 2025 | -99,710.49% |
| Jun 30, 2025 | -12,522.99% |
| Mar 31, 2025 | -30,860.11% |
| Jun 30, 2024 | -20,747.62% |
| Mar 31, 2024 | -11,488.91% |
| Sep 30, 2023 | -17,045.38% |
| Jun 30, 2023 | -5,363.87% |
| Mar 31, 2023 | -1,790.89% |
| Dec 31, 2022 | -6,707.48% |
| Sep 30, 2022 | -9,487.77% |
| Jun 30, 2022 | -9,805.24% |
| Mar 31, 2022 | -1,080.39% |
| Dec 31, 2021 | -2,865.31% |
| Dec 31, 2020 | 30,691.55% |
| Mar 31, 2020 | -25,045.07% |
| Dec 31, 2019 | -4,739.56% |
| Sep 30, 2019 | -3,015.64% |
| Mar 31, 2019 | -2,736.78% |
| Dec 31, 2018 | -1,207.55% |
| Sep 30, 2018 | -1,472.63% |
| Jun 30, 2018 | -864.99% |
| Mar 31, 2018 | -1,250.23% |
| Dec 31, 2017 | -473.67% |
| Sep 30, 2017 | -370.94% |
| Jun 30, 2017 | -197.48% |